MUCINEX
Pronunciation: gwye-FEN-e-sin


What it isExpectorant with incidental NMDA antagonism and an otherwise uncertain target; cough with thick secretions.
Why this oneThe only widely used oral expectorant, but its popularity greatly exceeds the strength of its evidence.
What limits itBenefit is often indistinguishable from hydration; stop if there is no clear response rather than escalating combination products.
Principal riskLittle
Legacy pregnancy categoryNot assigned — OTC/monograph
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Expectorant (OTC Uses): helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive | Adults and children >=12 y | 1 or 2 ER tablets (600 mg each) q12h | 1 or 2 ER tablets (600 mg each) q12h | 4 ER tablets per 24 h |
| Expectorant (OTC Uses): helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive | Children <12 y | Do not use | Do not use | Do not use |
Renal Undefined
Hepatic Undefined
Do not exceed 4 tablets in 24 hours.
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 600 mg | ER tab | 60 BID | $17.04 | out of stock |
| 1200 mg | ER tab | 60 BID | $25.90 | not offered |
Generic entryPre-1982
Open Guaifenesin in the interactive console ↗